Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

v3.19.3
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning balance at Dec. 31, 2017 $ 6 $ 36,202 $ (31,844) $ 4,364
Beginning balance, shares at Dec. 31, 2017 6,340,604      
Net proceeds from sale of common stock 466 466
Net proceeds from sale of common stock, shares 271,520      
Net proceeds from private placement of common stock $ 1 977 978
Net proceeds from private placement of common stock, shares 806,452      
Stock-based compensation expense 140 140
Stock-based compensation expense, shares      
Issuance of restricted stock 55 55
Issuance of restricted stock, shares 55,147      
Net loss (3,158) (3,158)
Ending balance at Sep. 30, 2018 $ 7 37,840 (35,002) 2,845
Ending balance, shares at Sep. 30, 2018 7,473,723      
Beginning balance at Jun. 30, 2018 $ 7 37,810 (34,091) 3,726
Beginning balance, shares at Jun. 30, 2018 7,473,723      
Stock-based compensation expense 30 30
Net loss (911) (911)
Ending balance at Sep. 30, 2018 $ 7 37,840 (35,002) 2,845
Ending balance, shares at Sep. 30, 2018 7,473,723      
Beginning balance at Dec. 31, 2018 $ 8 37,880 (35,067) 2,821
Beginning balance, shares at Dec. 31, 2018 7,481,723      
Net proceeds from sale of common stock 211 211
Net proceeds from sale of common stock, shares 111,129      
Net proceeds from private placement of common stock $ 1 1,849 1,850
Net proceeds from private placement of common stock, shares 1,267,123      
Issuance of common stock upon conversion of related party promissory note payable 250 250
Issuance of common stock upon conversion of related party promissory note payable, shares 171,233      
Stock-based compensation expense 93 93
Stock-based compensation expense, shares      
Issuance of restricted stock 211 211
Issuance of restricted stock, shares 145,700      
Net loss (3,071) (3,071)
Ending balance at Sep. 30, 2019 $ 9 40,494 (38,138) 2,365
Ending balance, shares at Sep. 30, 2019 9,176,908      
Beginning balance at Jun. 30, 2019 $ 9 40,462 (37,217) 3,254
Beginning balance, shares at Jun. 30, 2019 9,170,658      
Stock-based compensation expense 22 22
Issuance of restricted stock 10 10
Issuance of restricted stock, shares 6,250      
Net loss (921) (921)
Ending balance at Sep. 30, 2019 $ 9 $ 40,494 $ (38,138) $ 2,365
Ending balance, shares at Sep. 30, 2019 9,176,908